SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001619856-23-000096
Filing Date
2023-07-17
Accepted
2023-07-14 18:33:33
Documents
20
Period of Report
2023-07-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20230713.htm   iXBRL 8-K 35633
2 EX-1.1 underwritingagreement-exx11.htm EX-1.1 263382
3 EX-5.1 reedsmithopinion-exx51.htm EX-5.1 21064
4 EX-99.1 crbu-20230714xexx991launch.htm EX-99.1 10238
5 EX-99.2 crbu-20230714xexx992pricing.htm EX-99.2 10479
9 image_0a.jpg GRAPHIC 24840
10 image_1a.jpg GRAPHIC 37891
11 img25401123_0.jpg GRAPHIC 52289
12 img25401123_02.jpg GRAPHIC 52289
  Complete submission text file 0001619856-23-000096.txt   775777

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20230713.xsd EX-101.SCH 1910
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20230713_lab.xml EX-101.LAB 25850
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20230713_pre.xml EX-101.PRE 13587
14 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20230713_htm.xml XML 2916
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

IRS No.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 231090140
SIC: 2836 Biological Products, (No Diagnostic Substances)